UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping

Oct.04.2024
UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping
A UK study shows that there are 5.1 million e-cigarette users among people aged 16 and over, with the usage rate highest among the 16-24 age group at 15.8%. Over 1 million non-regular smokers have started using e-cigarettes, with usage increasing sevenfold over the past three years.

According to a recent report by The Guardian, research data shows that one in every ten people aged 16 and above in the UK is using e-cigarettes. The number of non-regular smokers in the UK who have started using e-cigarettes has increased sevenfold in three years, reaching 1 million. This has raised concerns among health experts.


Before 2021, the usage of e-cigarettes among non-regular adult smokers remained stable, with approximately 1 in 200 people, or about 133,000 individuals, using e-cigarettes. However, a study published in The Lancet Public Health indicates that by 2024, this proportion is projected to increase sharply to 1 in every 28 people, equating to 1.006 million individuals.


Data released this week by the Office for National Statistics in the UK reveals that there are a total of 5.1 million e-cigarette users aged 16 and over in the country. The age group with the highest e-cigarette usage rate is 16 to 24-year-olds, with a rate of 15.8%.


The study also found that the majority of e-cigarette users who had never smoked regularly are using e-cigarettes on a daily basis and for longer periods of time. This sharp increase is mainly driven by young people, with research showing that 14% of non-regular smokers aged 18 to 24 in the UK are now using e-cigarettes.


Researchers warn that the UK government's plans to ban disposable e-cigarettes may not fully address the issue, as some brands have already introduced reusable products. Experts suggest that reducing the appeal of e-cigarette products may require stricter regulations and laws.


Professor Jamie Brown from the Institute of Epidemiology and Health Care at University College London (UCL) believes that although measures to ban disposable e-cigarettes may not be enough to solve the problem, stricter regulations on the appearance, packaging, and marketing of products could be introduced. These measures are unlikely to reduce the effectiveness of e-cigarettes in smoking cessation. He points out that by 2023, the overall prevalence of e-cigarettes seems to be stabilizing, which may provide a reasonable basis for implementing these measures and assessing their effectiveness.


The study analyzed survey data from 153,073 adults in the UK between 2016 and 2024, of which 94,107 had never smoked regularly. The data showed that the proportion of non-smokers who used e-cigarettes increased from 0.5% in 2016-2020 to 3.5% by April 2024, surpassing 1 million people, with over half of them aged between 18 and 24.


Researchers also found that in recent years, the group of people who smoke irregularly tends to be younger, with an increase in the proportion of women. They are more likely to use disposable devices and high-concentration nicotine e-cigarette liquid, and mainly purchase products in supermarkets or convenience stores.


In a statement released by the Department of Health and Social Welfare in the UK, the department emphasized that although e-cigarettes can effectively help adults quit smoking, children and non-smoking adults should not use e-cigarettes. The department stated that the Tobacco and E-cigarette Act will protect future generations from the harms of tobacco and nicotine, save countless lives, and alleviate pressure on the national healthcare system.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
PMI reshuffles U.S. footprint: Swedish Match to shut Richmond office in April; most staff may be relocated
PMI reshuffles U.S. footprint: Swedish Match to shut Richmond office in April; most staff may be relocated
Swedish Match, a unit of Philip Morris International (PMI), will close its office in Richmond, Virginia, in April 2026 and eliminate 135 positions. PMI said the move is tied to adjustments in its U.S. operating footprint.
Feb.03
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
China’s 2026 “Two Sessions” reviewed the draft Outline of the 15th Five-Year Plan, which proposes implementing a health-first development strategy and strengthening the effectiveness of the Patriotic Health Campaign. Although the document does not address specific industries, this public-health governance framework provides a new policy context for observing the future regulation, product strategies, and market development of China’s tobacco and next-generation nicotine sectors.
Industry Insight
Mar.08
SICPA Secures Five-Year UK Vape Tax Stamp Contract
SICPA Secures Five-Year UK Vape Tax Stamp Contract
HM Revenue and Customs (HMRC) has awarded a five-year contract to Swiss technology company SICPA and Cartor Security Printers to implement the United Kingdom’s new vaping duty stamp and track-and-trace system, beginning in April 2026.
Market
Feb.24